Nuo Therapeutics, Inc. (AURX)

SG&A Expenses

$5.07M

TTM · Period ending: · USD

AURX logo

AURX SG&A Expenses

Latest reported$5.07M
AURX TTM SG&A Expenses ($1.79M → $5.07M)
High-resolution chart · PNG

AURX sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nuo Therapeutics, Inc. SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
5,065,996
4,922,291
4,734,605
4,404,592
4,086,895
3,735,441
3,520,166
3,390,224
3,510,380
3,638,065
3,650,707
3,867,421
3,843,065
3,797,686
3,413,630
2,460,816
1,523,947
606,767
90,670
342,652
342,155
249,161
302,606
297,815
819,576
1,447,091
1,919,657
2,143,497
2,136,112
2,536,415
2,978,584
3,869,181
4,536,664
5,009,098
5,466,748
5,796,578
6,826,439
8,098,091
10,238,434
12,827,931
15,258,026
16,729,539
17,376,399
17,633,427
17,074,699
16,481,769
16,465,882
16,357,877
17,414,918
17,552,352
17,312,958
16,773,907
16,157,964
14,455,251
12,335,484
10,323,843
7,936,414
8,045,436
8,164,566
8,078,994
7,285,376
6,538,387
5,577,589
4,954,122
4,829,353
4,877,184
5,169,196
5,543,166
5,694,853
5,757,743
7,399,056
6,735,402
6,514,825
6,176,823
4,669,871
4,802,664
5,092,834
5,114,038
6,349,985
7,496,743
8,060,484
8,882,783
8,164,722
8,078,998
8,622,124
8,115,780
7,256,000
6,283,839
4,460,194
4,314,190
3,498,540
2,541,397
2,000,815
873,742
1,128,403
1,506,494
1,981,343
2,648,879
2,558,520
2,256,863
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.